Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • Advancing NeuroMRI with High-Relaxivity Contrast Agents
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home

User menu

  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

ASHNR American Society of Functional Neuroradiology ASHNR American Society of Pediatric Neuroradiology ASSR
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • Advancing NeuroMRI with High-Relaxivity Contrast Agents
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds

AJNR Awards, New Junior Editors, and more. Read the latest AJNR updates


Improved Turnaround Times | Median time to first decision: 12 days

Research ArticleAdult Brain

Diffuse Large B-Cell Epstein-Barr Virus–Positive Primary CNS Lymphoma in Non-AIDS Patients: High Diagnostic Accuracy of DSC Perfusion Metrics

A. Pons-Escoda, A. García-Ruíz, P. Naval-Baudin, F. Grussu, M. Viveros, N. Vidal, J. Bruna, G. Plans, M. Cos, R. Perez-Lopez and C. Majós
American Journal of Neuroradiology October 2022, DOI: https://doi.org/10.3174/ajnr.A7668
A. Pons-Escoda
aFrom the Department of Radiology (A.P.-E., P.N.-B., M.V., M.C., C.M.)
dNeurooncology Unit (A.P.-E., N.V., J.B., G.P., C.M.), Institut d’Investigació Biomèdica de Bellvitge-IDIBELL, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for A. Pons-Escoda
A. García-Ruíz
eRadiomics Group (A.G.-R., F.G., R.P.-L.), Vall d’Hebron Institut d’Oncologia, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for A. García-Ruíz
P. Naval-Baudin
aFrom the Department of Radiology (A.P.-E., P.N.-B., M.V., M.C., C.M.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for P. Naval-Baudin
F. Grussu
eRadiomics Group (A.G.-R., F.G., R.P.-L.), Vall d’Hebron Institut d’Oncologia, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for F. Grussu
M. Viveros
aFrom the Department of Radiology (A.P.-E., P.N.-B., M.V., M.C., C.M.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for M. Viveros
N. Vidal
bPathology (N.V.)
dNeurooncology Unit (A.P.-E., N.V., J.B., G.P., C.M.), Institut d’Investigació Biomèdica de Bellvitge-IDIBELL, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for N. Vidal
J. Bruna
dNeurooncology Unit (A.P.-E., N.V., J.B., G.P., C.M.), Institut d’Investigació Biomèdica de Bellvitge-IDIBELL, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for J. Bruna
G. Plans
dNeurooncology Unit (A.P.-E., N.V., J.B., G.P., C.M.), Institut d’Investigació Biomèdica de Bellvitge-IDIBELL, Barcelona, Spain
cNeurosurgery (G.P.), Hospital Universitari de Bellvitge, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for G. Plans
M. Cos
aFrom the Department of Radiology (A.P.-E., P.N.-B., M.V., M.C., C.M.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for M. Cos
R. Perez-Lopez
eRadiomics Group (A.G.-R., F.G., R.P.-L.), Vall d’Hebron Institut d’Oncologia, Barcelona, Spain
fDepartment of Radiology (R.P.-L.), Hospital Universitari Vall d’Hebron, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for R. Perez-Lopez
C. Majós
aFrom the Department of Radiology (A.P.-E., P.N.-B., M.V., M.C., C.M.)
dNeurooncology Unit (A.P.-E., N.V., J.B., G.P., C.M.), Institut d’Investigació Biomèdica de Bellvitge-IDIBELL, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for C. Majós
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • Responses
  • References
  • PDF
Loading

References

  1. 1.↵
    1. Chiavazza C,
    2. Pellerino A,
    3. Ferrio F, et al
    . Primary CNS lymphomas: challenges in diagnosis and monitoring. Biomed Res Int 2018;2018:3606970 doi:10.1155/2018/3606970 pmid:30035121
    CrossRefPubMed
  2. 2.↵
    1. Qian L,
    2. Tomuleasa C,
    3. Florian I-A, et al
    . Advances in the treatment of newly diagnosed primary central nervous system lymphomas. Blood Res 2017;52:159–66 doi:10.5045/br.2017.52.3.159 pmid:29043230
    CrossRefPubMed
  3. 3.↵
    1. Bühring U,
    2. Herrlinger U,
    3. Krings T, et al
    . MRI features of primary central nervous system lymphomas at presentation. Neurology 2001;57:393–96 doi:10.1212/wnl.57.3.393 pmid:11515505
    CrossRefPubMed
  4. 4.↵
    1. Malikova H,
    2. Koubska E,
    3. Weichet J, et al
    . Can morphological MRI differentiate between primary central nervous system lymphoma and glioblastoma? Cancer Imaging 2016;16:40 doi:10.1186/s40644-016-0098-9 pmid:27894359
    CrossRefPubMed
  5. 5.↵
    1. Mansour A,
    2. Qandeel M,
    3. Abdel-Razeq H, et al
    . MR imaging features of intracranial primary CNS lymphoma in immune competent patients. Cancer Imaging 2014;14:22 doi:10.1186/1470-7330-14-22 pmid:25608570
    CrossRefPubMed
  6. 6.↵
    1. Haldorsen IS,
    2. Espeland A,
    3. Larsson EM
    . Central nervous system lymphoma: characteristic findings on traditional and advanced imaging. AJNR Am J Neuroradiol 2011;32:984–92 doi:10.3174/ajnr.A2171 pmid:20616176
    Abstract/FREE Full Text
  7. 7.↵
    1. Tang YZ,
    2. Booth TC,
    3. Bhogal P, et al
    . Imaging of primary central nervous system lymphoma. Clin Radiol 2011;66:768–77 doi:10.1016/j.crad.2011.03.006 pmid:21513925
    CrossRefPubMed
  8. 8.↵
    WHO Classification of Tumours Editorial Board. World Health Organization Classification of Tumours of the Central Nervous System. 5th ed. International Agency for Research on Cancer; 2021
  9. 9.↵
    1. Sauter A,
    2. Faul C,
    3. Bitzer M, et al
    . Imaging findings in immunosuppressed patients with Epstein Barr virus-related B cell malignant lymphoma. AJR Am J Roentgenol 2010;194:141–49 doi:10.2214/AJR.09.3264 pmid:20093565
    CrossRefPubMed
  10. 10.↵
    1. Lee HY,
    2. Kim HS,
    3. Park JW, et al
    . Atypical imaging features of Epstein-Barr virus-positive primary central nervous system lymphomas in patients without AIDS. AJNR Am J Neuroradiol 2013;34:1562–67 doi:10.3174/ajnr.A3429 pmid:23413244
    Abstract/FREE Full Text
  11. 11.↵
    1. Jiménez de la Peña M del M,
    2. Vicente LG,
    3. Alonso RC, et al
    . The multiple faces of nervous system lymphoma. Atypical magnetic resonance imaging features and contribution of the advanced imaging. Curr Probl Diagn Radiol 2017;46:136–45 doi:10.1067/j.cpradiol.2016.04.004 pmid:27475832
    CrossRefPubMed
  12. 12.↵
    1. Lin X,
    2. Khan IRA,
    3. Seet YH, et al
    . Atypical radiological findings of primary central nervous system lymphoma. Neuroradiology 2020;62:669–76 doi:10.1007/s00234-020-02377-0 pmid:32077984
    CrossRefPubMed
  13. 13.↵
    1. Shin DJ,
    2. Lee EJ,
    3. Lee JE, et al
    . Common and uncommon features of central nervous system lymphoma on traditional and advanced imaging modalities. Neurographics 2017;7:437–49 doi:10.3174/ng.9170229
    CrossRef
  14. 14.↵
    1. Suh CH,
    2. Kim HS,
    3. Lee SS, et al
    . Atypical imaging features of primary central nervous system lymphoma that mimics glioblastoma: utility of intravoxel incoherent motion MR imaging. Radiology 2014;272:504–13 doi:10.1148/radiol.14131895 pmid:24697149
    CrossRefPubMed
  15. 15.↵
    1. Swerdlow SH,
    2. Campo E,
    3. Pileri SA, et al
    . The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 2016;127:2375–90 doi:10.1182/blood-2016-01-643569 pmid:26980727
    Abstract/FREE Full Text
  16. 16.↵
    1. Gandhi MK,
    2. Hoang T,
    3. Law SC, et al
    . EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity. Blood 2021;137:1468–77 doi:10.1182/blood.2020008520 pmid:33202420
    CrossRefPubMed
  17. 17.↵
    1. Mahale P,
    2. Shiels MS,
    3. Lynch CF, et al
    . Incidence and outcomes of primary central nervous system lymphoma in solid organ transplant recipients. Am J Transplant 2018;18:453–61 doi:10.1111/ajt.14465 pmid:28805292
    CrossRefPubMed
  18. 18.↵
    1. Verdu-Bou M,
    2. Tapia G,
    3. Hernandez-Rodriguez A, et al
    . Clinical and therapeutic implications of Epstein–Barr virus in HIV-related lymphomas. Cancers (Basel) 2021;13:5534 doi:10.3390/cancers13215534 pmid:34771697
    CrossRefPubMed
  19. 19.↵
    1. Kaulen LD,
    2. Karschnia P,
    3. Dietrich J, et al
    . Autoimmune disease-related primary CNS lymphoma: systematic review and meta-analysis. J Neurooncol 2020;149:153–59 doi:10.1007/s11060-020-03583-9 pmid:32683530
    CrossRefPubMed
  20. 20.↵
    1. Mancuso S,
    2. Carlisi M,
    3. Santoro M, et al
    . Immunosenescence and lymphomagenesis. Immun Ageing 2018;15:22 doi:10.1186/s12979-018-0130-y pmid:30258468
    CrossRefPubMed
  21. 21.↵
    1. Barosi G
    . An immune dysregulation in MPN. Curr Hematol Malig Rep 2014;9:331–39 doi:10.1007/s11899-014-0227-0 pmid:25139710
    CrossRefPubMed
  22. 22.↵
    1. Pons-Escoda A,
    2. Garcia-Ruiz A,
    3. Naval-Baudin P, et al
    . Presurgical identification of primary central nervous system lymphoma with normalized time-intensity curve: a pilot study of a new method to analyze DSC-PWI. AJNR Am J Neuroradiol 2020;41:1816–24 doi:10.3174/ajnr.A6761 pmid:32943424
    Abstract/FREE Full Text
  23. 23.↵
    1. Pons-Escoda A,
    2. Garcia-Ruiz A,
    3. Naval-Baudin P, et al
    . Voxel-level analysis of normalized DSC-PWI time-intensity curves: a potential generalizable approach and its proof of concept in discriminating glioblastoma and metastasis. Eur Radiol 2022;32:3705–15 doi:10.1007/s00330-021-08498-1 pmid:35103827
    CrossRefPubMed
  24. 24.↵
    1. Lee MD,
    2. Baird GL,
    3. Bell LC, et al
    . Utility of percentage signal recovery and baseline signal in DSC-MRI optimized for relative CBV measurement for differentiating glioblastoma, lymphoma, metastasis, and meningioma. AJNR Am J Neuroradiol 2019;40:1445–50 doi:10.3174/ajnr.A6153 pmid:31371360
    Abstract/FREE Full Text
  25. 25.↵
    1. Xing Z,
    2. You RX,
    3. Li J, et al
    . Differentiation of primary central nervous system lymphomas from high-grade gliomas by rCBV and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Clin Neuroradiol 2014;24:329–36 doi:10.1007/s00062-013-0255-5 pmid:23994941
    CrossRefPubMed
  26. 26.↵
    1. Neska-Matuszewska M,
    2. Bladowska J,
    3. Sąsiadek M, et al
    . Differentiation of glioblastoma multiforme, metastases and primary central nervous system lymphomas using multiparametric perfusion and diffusion MR imaging of a tumor core and a peritumoral zone: searching for a practical approach. PLoS One 2018;13:e0191341 doi:10.1371/journal.pone.0191341 pmid:29342201
    CrossRefPubMed
  27. 27.↵
    1. Wang S,
    2. Kim S,
    3. Chawla S, et al
    . Differentiation between glioblastomas, solitary brain metastases, and primary cerebral lymphomas using diffusion tensor and dynamic susceptibility contrast-enhanced MR imaging. AJNR Am J Neuroradiol 2011;32:507–14 doi:10.3174/ajnr.A2333 pmid:21330399
    Abstract/FREE Full Text
  28. 28.↵
    1. Lee IH,
    2. Kim ST,
    3. Kim HJ, et al
    . Analysis of perfusion weighted image of CNS lymphoma. Eur J Radiol 2010;76:48–51 doi:10.1016/j.ejrad.2009.05.013 pmid:19500931
    CrossRefPubMed
  29. 29.↵
    1. Calli C,
    2. Kitis O,
    3. Yunten N, et al
    . Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors. Eur J Radiol 2006;58:394–403 doi:10.1016/j.ejrad.2005.12.032 pmid:16527438
    CrossRefPubMed
  30. 30.↵
    1. Mangla R,
    2. Kolar B,
    3. Zhu T, et al
    . Percentage signal recovery derived from MR dynamic susceptibility contrast imaging is useful to differentiate common enhancing malignant lesions of the brain. AJNR Am J Neuroradiol 2011;32:1004–10 doi:10.3174/ajnr.A2441 pmid:21511863
    Abstract/FREE Full Text
  31. 31.↵
    1. Boxerman JL,
    2. Schmainda KM ,
    3. Weisskoff RM
    . Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. AJNR Am J Neuroradiol 2006;27:859–67 pmid:16611779
    PubMedWeb of Science
  32. 32.↵
    1. Cha S,
    2. Lupo JM,
    3. Chen MH, et al
    . Differentiation of glioblastoma multiforme and single brain metastasis by peak height and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. AJNR Am J Neuroradiol 2007;28:1078–84 doi:10.3174/ajnr.A0484 pmid:17569962
    CrossRefPubMedWeb of Science
  33. 33.↵
    1. Corn BW,
    2. Marcus SM,
    3. Topham A, et al
    . Will primary central nervous system lymphoma be the most frequent brain tumor diagnosed in the year 2000? Cancer 1997;79:2409–13 pmid:9191531
    CrossRefPubMedWeb of Science
  34. 34.↵
    1. Kadan-Lottick NS,
    2. Skluzacek MC,
    3. Gurney JG
    . Decreasing incidence rates of primary central nervous system lymphoma. Cancer 2002;95:193–202 doi:10.1002/cncr.10643 pmid:12115333
    CrossRefPubMedWeb of Science
  35. 35.↵
    1. De Robles P,
    2. Fiest KM,
    3. Frolkis AD, et al
    . The worldwide incidence and prevalence of primary brain tumors: a systematic review and meta-analysis. Neuro Oncol 2015;17:776–83 doi:10.1093/neuonc/nou283 pmid:25313193
    CrossRefPubMed
  36. 36.↵
    1. Adachi K,
    2. Yamaguchi F,
    3. Node Y, et al
    . Neuroimaging of primary central nervous system lymphoma in immunocompetent patients: comparison of recent and previous findings. J Nippon Med Sch 2013;80:174–83 doi:10.1272/jnms.80.174 pmid:23832401
    CrossRefPubMed
  37. 37.↵
    1. Wang ZD,
    2. Liu HH,
    3. Ma ZX, et al
    . Toxoplasma gondii infection in immunocompromised patients: a systematic review and meta-analysis. Front Microbiol 2017;8:1–12 doi:10.3389/fmicb.2017.00389] pmid:28197127
    CrossRefPubMed
  38. 38.↵
    1. Arendt G,
    2. Maschke M
    . Update: opportunistic infections of the central nervous system in patients with iatrogenic immunosuppression: an update. Neurology International Open 2017;1:E316–25 doi:10.1055/s-0043-118924
    CrossRef
  39. 39.↵
    1. Morollón N,
    2. Rodríguez F,
    3. Duarte J, et al
    . Brain lesions in a long-term kidney transplant recipient: primary cerebral lymphoma or cerebral toxoplasmosis? Neurologia 2017;32:268–70 doi:10.1016/j.nrleng.2015.06.016 pmid:26383060
    CrossRefPubMed
  40. 40.↵
    1. Cindil E,
    2. Sendur HN,
    3. Cerit MN, et al
    . Validation of combined use of DWI and percentage signal recovery-optimized protocol of DSC-MRI in differentiation of high-grade glioma, metastasis, and lymphoma. Neuroradiology 2021;63:331–42 doi:10.1007/s00234-020-02522-9 pmid:32821962
    CrossRefPubMed
PreviousNext
Back to top
Advertisement
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Diffuse Large B-Cell Epstein-Barr Virus–Positive Primary CNS Lymphoma in Non-AIDS Patients: High Diagnostic Accuracy of DSC Perfusion Metrics
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Cite this article
A. Pons-Escoda, A. García-Ruíz, P. Naval-Baudin, F. Grussu, M. Viveros, N. Vidal, J. Bruna, G. Plans, M. Cos, R. Perez-Lopez, C. Majós
Diffuse Large B-Cell Epstein-Barr Virus–Positive Primary CNS Lymphoma in Non-AIDS Patients: High Diagnostic Accuracy of DSC Perfusion Metrics
American Journal of Neuroradiology Oct 2022, DOI: 10.3174/ajnr.A7668

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
0 Responses
Respond to this article
Share
Bookmark this article
Diffuse Large B-Cell Epstein-Barr Virus–Positive Primary CNS Lymphoma in Non-AIDS Patients: High Diagnostic Accuracy of DSC Perfusion Metrics
A. Pons-Escoda, A. García-Ruíz, P. Naval-Baudin, F. Grussu, M. Viveros, N. Vidal, J. Bruna, G. Plans, M. Cos, R. Perez-Lopez, C. Majós
American Journal of Neuroradiology Oct 2022, DOI: 10.3174/ajnr.A7668
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Purchase

Jump to section

  • Article
    • Abstract
    • ABBREVIATIONS:
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSIONS
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • Responses
  • References
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • Unpacking the CNS Manifestations of Epstein-Barr Virus: An Imaging Perspective
  • Imaging of Lymphomas Involving the CNS: An Update-Review of the Full Spectrum of Disease with an Emphasis on the World Health Organization Classifications of CNS Tumors 2021 and Hematolymphoid Tumors 2022
  • Crossref
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

More in this TOC Section

  • Diagnostic Neuroradiology of Monoclonal Antibodies
  • Cerebral ADC Changes in Fabry Disease
  • ML for Glioma Molecular Subtype Prediction
Show more Adult Brain

Similar Articles

Advertisement

Indexed Content

  • Current Issue
  • Accepted Manuscripts
  • Article Preview
  • Past Issues
  • Editorials
  • Editor's Choice
  • Fellows' Journal Club
  • Letters to the Editor
  • Video Articles

Cases

  • Case Collection
  • Archive - Case of the Week
  • Archive - Case of the Month
  • Archive - Classic Case

More from AJNR

  • Trainee Corner
  • Imaging Protocols
  • MRI Safety Corner
  • Book Reviews

Multimedia

  • AJNR Podcasts
  • AJNR Scantastics

Resources

  • Turnaround Time
  • Submit a Manuscript
  • Submit a Video Article
  • Submit an eLetter to the Editor/Response
  • Manuscript Submission Guidelines
  • Statistical Tips
  • Fast Publishing of Accepted Manuscripts
  • Graphical Abstract Preparation
  • Imaging Protocol Submission
  • Evidence-Based Medicine Level Guide
  • Publishing Checklists
  • Author Policies
  • Become a Reviewer/Academy of Reviewers
  • News and Updates

About Us

  • About AJNR
  • Editorial Board
  • Editorial Board Alumni
  • Alerts
  • Permissions
  • Not an AJNR Subscriber? Join Now
  • Advertise with Us
  • Librarian Resources
  • Feedback
  • Terms and Conditions
  • AJNR Editorial Board Alumni

American Society of Neuroradiology

  • Not an ASNR Member? Join Now

© 2025 by the American Society of Neuroradiology All rights, including for text and data mining, AI training, and similar technologies, are reserved.
Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire